DM management part 2 Flashcards

1
Q

what are the possible injection site reactions of insulin injections

A

inflammation
fibrosis
pain
lpohypertrophy
lipoatrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the rapid acting insulins

A

lispro (humalog)
aspart (novolog)
glulisine (apidra)
technosphere (afrezza)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the inhaled insulin

A

technosphere (afrezza)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the short acting insulin

A

human regular (humulin R, novolin R)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the intermediate acting insulin

A

human NPH (HUmulin, novolin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the long acting insulins

A

detemir (levemir)
glargine U100 (lantus)
glargine U300 (toujeo)
degludec

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

low insulin in the morning resulting in hyperglycemia due to the nocturnal release of glucagon

A

dawn phenomenon
treated by taking more insulin at night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

treated by taking more insulin at night

A

dawn phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is a treatment practice used to help with portion control and insulin bolus doings? what are common starting guidelines?

A

carb counting
males - 60g per meal 30 g per snack
females - 45g per meal 15g per snack

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

hyperglycemia in the morning as a result of excess exogenous insulin at night. often a result of hypoglycemia at night, which is regulated and then converted to rebound hyperglycemia in the morning

A

somogyi effect
treated by decreasing insulin at night

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

treated by decreasing insulin at night

A

somogyi efect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

3AM check shows BG of 39

A

somogyi effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

3AM check shows BG of 94

A

dawn effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

decreased insulin at bedtime causes improvement in morning hyperglycemia

A

somogyi effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

decreased insulin at bedtime results in worse or persisting hyperglycemia

A

dawn phenomenon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is the alternate dosing for the physiologic dosing regimen

A

can use carb counting:
1 U per 15g of carb PLUS
1 U for every 50mg/dL of BG at pre meal screening above a set goal

17
Q

what insulin is preferred for basal dosing, why?

A

long acting insulins preferred over NPH
because long acting:
* more predictable absorption
* closer to endogenous insulin release pattern
* QD dosing
* less hypoglycemia

18
Q

what even is this slide, just flip it

A
19
Q

fixes a leaky liver

A

metformin (biguinides)

  • inhibits hepatic gluconeogenesis
  • decreases intestinal absorption of glucose
  • slightly improves insulin sensitivity
20
Q

BBW for lactic acidosis

A

metformin

21
Q

what are the locksmiths

A

TZD (thiazolinediones) - rosiglitazone and pioglitazone
* “unlock” muscle and fat cells to help utilize glucose.
* improves insulin sensitivity and increases peripheral tissue glucose uptake
* decreased gluconeogenesis
* increased adipogenesis

22
Q

what medications bind to PRAR-gamma

A

TZDs

23
Q

weight gain, edema, anemia, fracture risk

A

TZDs

24
Q

bladder cancer risk

A

pioglitazone

25
Q

BBW for CHF

A

TZDs

26
Q

BBW for MI

A

rosiglitazone

27
Q

worsens TC, LDL, increases HDL

A

rosiglitazone

28
Q

CI in CHF, caution with liver disease and osteoporosis risk

A

TZDs

29
Q

who are the electricians

A

sulfonylureas and meglitinides zap the pancreas to stimulate increased production of insulin

(bind to a site on K+ channel which leads to release of insulin)